Older HPV-Positive Oropharyngeal Cancer Patients Have High Treatment Tolerability

October 20, 2017

This video examines results of a study that looked at treatment tolerability in elderly patients with HPV-positive oropharyngeal squamous cell carcinoma.

In this video, Richard Bakst, MD, of the Icahn School of Medicine at Mount Sinai in New York, discusses a study that examined treatment tolerability and outcomes in elderly patients (65 years and older) with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma.

Bakst presented the results of the study (abstract 2764) at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, held September 24–27 in San Diego.